loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Drug Master Files (DMF) for 20609 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Aarti Pharmalabs

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    INTERMEDIATES

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Aarti Pharmalabs (1)

    filter

    01 BUDESONIDE USP (1)

    filter

    01 India (1)

    filter

    01 Active (1)

    filter

    01 Complete (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    AARTI PHARMALABS LTD

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual BoothAarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    BUDESONIDE USP

    PDF Supplier PDF
    URL Supplier Web Content
    20609
    Active
    2007-06-13
    Complete
    2014-04-03
    2013-03-04
    II
    Aarti Industries Company Banner

    CPhI China

    Booth #E1C28

    envelop Contact Supplier

    Looking for Drug Master Files (DMF) for 20609 of Aarti Pharmalabs Ltd

    Looking for Drug Master Files (DMF) for 20609 of Aarti Pharmalabs Ltd 1

    20

    Aarti Pharmalabs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    They are recognized for Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.

    One of their notable products is BUDESONIDE USP, with a corresponding US DMF Number 20609.

    Remarkably, this DMF maintains an Active status since its submission on June 13, 2007, highlighting commitment to regulatory compliance.

    Their GDUFA DMF Review was successfully complete, with a review date of April 03, 2014, and payment made on March 04, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II

    Post Enquiry
    POST ENQUIRY